and/or aims): Bile acid synthesis in the liver is a major pathway for the catabolism of cholesterol in mammals and is regulated at the rate-limiting enzyme, cholesterol 7- alpha-hydroxylase. However, the molecular mechanism of regulation of bile acid synthesis has not been elucidated. The enterohepatic circulation of bile is the major physiological control of bile acid biosynthesis, which exerts a negative feedback regulation of the cholesterol 7-alpha-hydroxylase gene (CYP7) transcription. Cholesterol and steroid/thyroid hormones also regulate this gene at the transcriptional level. To achieve the long-range objectives to elucidate the molecular mechanism of this regulatory gene and mechanisms of human diseases involving cholesterol and bile acid metabolisms, the applicant and his collaborators designed experiments with the following specific aims: (1) to map the promoter and cis-regulatory elements of the human CYP7 gene by transient transfection assays of the CYP7/luciferase chimeric gene constructs in HepG2 cells; (2) to identify trans-regulatory protein factors conferring bile acids, cholesterol and hormones regulations, DNase I footprinting, electrophoretic mobility shift assay (EMSA), and protein blotting assays will be used to study DNA-protein interactions; (3) to isolate transacting protein factors conferring bile acid repression, bile acid responsive element identified will be used to screen human liver cDNA expression libraries for cDNAs encoding protein factors and to isolate human liver nuclear DNA-binding proteins by recognition site-affinity chromatography; (4) to confirm the functions of transcription factors regulating the human CYP7 gene/LUC constructs with transcription factor expression plasmids, and EMSA and footprinting assays using over-expressed transcription factors will be performed to study the gene regulation. Elucidation of the structure, function and regulation of this important gene in bile acid synthesis could contribute to the understanding of the mechanisms and regulation of cholesterol homeostasis in humans.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK044442-01A3
Application #
2143793
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1994-08-01
Project End
1997-07-31
Budget Start
1994-08-01
Budget End
1995-07-31
Support Year
1
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Northeast Ohio Medical University
Department
Biochemistry
Type
Schools of Medicine
DUNS #
City
Rootstown
State
OH
Country
United States
Zip Code
44272
Donepudi, Ajay C; Ferrell, Jessica M; Boehme, Shannon et al. (2018) Deficiency of cholesterol 7?-hydroxylase in bile acid synthesis exacerbates alcohol-induced liver injury in mice. Hepatol Commun 2:99-112
Pathak, Preeti; Xie, Cen; Nichols, Robert G et al. (2018) Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism. Hepatology 68:1574-1588
Chiang, John Y L; Ferrell, Jessica M (2018) Bile Acid Metabolism in Liver Pathobiology. Gene Expr 18:71-87
Chiang, John Y L (2017) Linking Sex Differences in Non-Alcoholic Fatty Liver Disease to Bile Acid Signaling, Gut Microbiota, and High Fat Diet. Am J Pathol 187:1658-1659
Chiang, John Y L (2017) Linking long noncoding RNA to control bile acid signaling and cholestatic liver fibrosis. Hepatology 66:1032-1035
Chiang, John Y L; Pathak, Preeti; Liu, Hailiang et al. (2017) Intestinal Farnesoid X Receptor and Takeda G Protein Couple Receptor 5 Signaling in Metabolic Regulation. Dig Dis 35:241-245
Chiang, John Y L (2017) Bile acid metabolism and signaling in liver disease and therapy. Liver Res 1:3-9
Pathak, Preeti; Liu, Hailiang; Boehme, Shannon et al. (2017) Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism. J Biol Chem 292:11055-11069
Donepudi, Ajay C; Boehme, Shannon; Li, Feng et al. (2017) G-protein-coupled bile acid receptor plays a key role in bile acid metabolism and fasting-induced hepatic steatosis in mice. Hepatology 65:813-827
Chiang, John Y L (2017) Targeting bile acids and lipotoxicity for NASH treatment. Hepatol Commun 1:1002-1004

Showing the most recent 10 out of 88 publications